Heterodimer-specific TLR2 stimulation results in divergent functional outcomes in B-cell precursor acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Heterodimer-specific TLR2 stimulation results in divergent functional outcomes in B-cell precursor acute lymphoblastic leukemia

Published:2015-05-06 Issue:7 Volume:45 Page:1980-1990
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Rolf Nina¹,Kariminia Amina¹,Ivison Sabine¹,Reid Gregor S.¹,Schultz Kirk R.¹

Affiliation:

1. The Michael Cuccione Childhood Cancer Research Program, Child and Family Research Institute and Division of Pediatric Hem/Onc/BMT; Department of Pediatrics; University of British Columbia; Vancouver BC Canada

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/eji.201444874/fullpdf

Reference92 articles.

1. Bioimmunoadjuvants for the treatment of neoplastic and infectious disease: Coley's legacy revisited;Decker;Cytokine Growth Factor Rev,2009

2. Trial watch: experimental Toll-like receptor agonists for cancer therapy;Galluzzi;Oncoimmunology,2012

3. TLR agonists: our best frenemy in cancer immunotherapy;Kaczanowska;J. Leukoc. Biol.,2013

4. Pathogen-associated molecular pattern in cancer immunotherapy;Hobohm;Crit. Rev. Immunol.,2008

5. Toll-like receptors and cancer;Rakoff-Nahoum;Nat. Rev. Cancer.,2009

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fatty acids of Helicobacter pylori lipoproteins CagT and Lpp20;Microbiology Spectrum;2024-05-02

2. Harnessing innate immune pathways for therapeutic advancement in cancer;Signal Transduction and Targeted Therapy;2024-03-25

3. Spontaneous remission of acute lymphoblastic leukemia: A series of nine cases and a review of literature;International Journal of Laboratory Hematology;2023-02-20

4. IL-1β expression in bone marrow dendritic cells is induced by TLR2 agonists and regulates HSC function;Blood;2022-10-06

5. Unleashing Cell-Intrinsic Inflammation as a Strategy to Kill AML Blasts;Cancer Discovery;2022-04-11